SUPERIOR VENA CAVA SYNDROME

This adverse event was reported 604 times

These drugs are most commonly taken by patients reporting SUPERIOR VENA CAVA SYNDROME:

# Drug Count
0 CARBOPLATIN 56
1 ETOPOSIDE 49
2 CYCLOPHOSPHAMIDE 48
3 CYCLOPHOSPHAMIDE FOR INJECTION 48
4 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 48
5 BEVACIZUMAB 47
6 PACLITAXEL 44
7 PREDNISONE 44
8 NIVOLUMAB 40
9 DEXAMETHASONE 35
See all common drugs associated with SUPERIOR VENA CAVA SYNDROME

SUPERIOR VENA CAVA SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ZIV-AFLIBERCEPT 5 0.0038
1 VINORELBINE 14 0.0020
2 DEFLAZACORT 5 0.0019
3 AMOXICILLIN AND CLAVULANATE POTASSIUM 6 0.0013
4 ALGLUCOSIDASE ALFA 3 0.0012
5 COAGULATION FACTOR VIIA (RECOMBINANT) 3 0.0011
6 ERIBULIN MESYLATE 4 0.0011
7 LAPATINIB 16 0.0010
8 VANCOMYCIN HYDROCHLORIDE 7 0.0008
9 BRIGATINIB 3 0.0008
See all drugs enriched for association with SUPERIOR VENA CAVA SYNDROME